Ethyl 2-((6-chloropyridazin-4-yl)oxy)acetate

Catalog No.: 
ACMJDC137
CAS No.: 
1346691-36-8
Molecular Formula: 
C8H9ClN2O3
Molecular Weight: 
216.62
Ethyl 2-((6-chloropyridazin-4-yl)oxy)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$466.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-((6-chloropyridazin-4-yl)oxy)acetate
IUPAC Nameethyl 2-((6-chloropyridazin-4-yl)oxy)acetate
MDL No.MFCD19688852
Molecular FormulaC8H9ClN2O3
Molecular Weight216.62
SMILESO=C(OCC)COC1=CC(Cl)=NN=C1
InChI KeyITQOWKCODKBRGY-UHFFFAOYSA-N
Synonymethyl 2-(6-chloropyridazin-4-yloxy)acetate
CAS No.1346691-36-8

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMJDC137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOTQ063 route compound structure diagram
    ACCOTQ0631415928-75-4In Stock
  4. Then
  5. ACMJDC137 route product structure diagram
    ACMJDC1371346691-36-8
Inquiry

2. ACMJDC137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDUI364 route compound structure diagram
    ACPDUI364623-50-7In Stock
  2. Plus
  3. ACENAW254 route compound structure diagram
    ACENAW2541837-55-4In Stock
  4. Then
  5. ACMJDC137 route product structure diagram
    ACMJDC1371346691-36-8
Inquiry

3. ACMJDC137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDUI364 route compound structure diagram
    ACPDUI364623-50-7In Stock
  2. Plus
  3. ACUGAQ384 route compound structure diagram
    ACUGAQ3841196155-33-5In Stock
  4. Then
  5. ACMJDC137 route product structure diagram
    ACMJDC1371346691-36-8
Inquiry

Comments (0)